Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.
[EN] NOVEL GLUCAGON ANTAGONISTS<br/>[FR] NOUVEAUX ANTAGONISTES DU GLUCAGON
申请人:NOVO NORDISK AS
公开号:WO2004056763A2
公开(公告)日:2004-07-08
Novel compounds that act to antagonize the action of the glucagon peptide hormone on the glucagon receptor. More particularly, it relates to glucagon antagonists or inverse agonists.